How I lost 90% of my accounts in October last year : stocks


I started investing/trading in August 2020. I had a few big initial successes and failures, my strategy back then was shorting overvalued stocks and go long for undervalued stocks. If my convictions are high, I would go all in on options. It worked at first but quickly backfired, so I became more careful with the options.

In June last year, I started shorting snowflakes ($SNOW) (I had shorted it before, but went back shorting it after seeing it bounce back up), I had some initial successes but as it grinds up, I had to use more and more leverage in order to break even.

In October last year, I could no longer add more leverage, and the share price at that time was at around 320. I figured that the price couldn’t stay up there for long so I went all in (again! because I had enough of the steady uptrend) on long dated deep ITM puts. I thought it couldn’t possibly go tits up, as market will price in rate hike soon, plus some technicals.

As the price goes up further, my puts drained in value. I figured, why not leverage up more so I get my money back faster? Great idea, and I sold 370P to 300P. And then I saw my account consistently losing 10k~20k a day in the next couple of weeks.

This is how I lost 90% of my accounts.

View post on imgur.com



Source link

Related articles

Pump.enjoyable Declares New Upgrades to Creator Charge Mannequin

Pump.enjoyable has acknowledged that there can be adjustments to its creator price mannequin, which triggered a spike within the worth of its native token, PUMP. In keeping with the information by TradingView,...

The Hidden Tradition Dangers Of Fast Progress And How Leaders Can Counter Them

Fast progress — of a staff, division, or firm — is commonly coupled with an underestimation of the cultural...

European inventory markets end the week sturdy

The non-farm payrolls got here in a bit softer than the whisper numbers, giving the "dangerous information is sweet information" crowd a purpose to cheer. For the ECB, it does not change a...

BridgeBio Pharma, Inc. (BBIO) Discusses Achondroplasia Pathophysiology, Unmet Wants, and PROPEL 3 Infigratinib Part 3 Examine Transcript

ObservePlay Earnings NamePlay Earnings Name BridgeBio Pharma, Inc. (BBIO) Discusses Achondroplasia Pathophysiology, Unmet Wants, and PROPEL 3 Infigratinib Part 3 Examine January 9, 2026 8:00 AM EST Firm Contributors Justin ToDaniela...

Anker’s new AeroFit Professional 2 earbuds are already $30 off

We noticed a ton of cool new merchandise at CES 2026, however not all of them made the minimize when it got here to deciding what was better of present. A kind of...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com